Characteristics and clinical significance of histological variants of bladder cancer

@article{Moschini2017CharacteristicsAC,
  title={Characteristics and clinical significance of histological variants of bladder cancer},
  author={Marco Moschini and David D’andrea and Stephan M. Korn and Yasin Irmak and Francesco Soria and Eva Comp{\'e}rat and Shahrokh Francois Shariat},
  journal={Nature Reviews Urology},
  year={2017},
  volume={14},
  pages={651-668}
}
In the past 10 years evidence for the clinical relevance of variant histology in urinary bladder cancer has been increasing. This increase has resulted in new classifications of urothelial cancers by the WHO in 2016, highlighting the importance of an accurate morphological description of pathological specimens for the therapeutic management of patients with bladder cancer. The rising awareness of the importance of an accurate pathological report manifests itself in the increasing prevalence of… 
Variants and new entities of bladder cancer
TLDR
This review will discuss the features of variants of urothelial carcinoma in the context of the current clinical practice of bladder cancer, and include some new entities not included in the current WHO classification of u rothelial tumours.
Non-Muscle Invasive Bladder Cancer with Variant Histology: Biological Features and Clinical Implications
TLDR
The presence of VH should be taken into account when counseling a patient with NMIBC, since it may upgrade the disease to high-risk tumor and thus warrant a more aggressive treatment.
Histological variants in non-muscle invasive bladder cancer
TLDR
The neuroendocrine differentiation showed chemosensitiveness, and RC preceded by neoadjuvant chemotherapy should be proposed, and treatment of BCa with variant histology shall include immediate RC in case of plasmacitoid, pure squamous, micropapillary and sarcomatoid variants.
Bladder Cancer Variant Histologies: Epidemiology, Diagnosis, Treatment and Prognosis
TLDR
This chapter aims to summarize the current literature on the most common histologic variants regarding their epidemiology, clinical presentation at diagnosis, treatment options and prognosis, and a special focus will be placed on the role of neoadjuvant chemotherapy and early cystectomy and its prognostic implications.
Clear Cell carcinoma of the urinary bladder, A case report: Surgical and oncological management.
  • E. Corongiu, P. Grande, V. Olivieri
  • Medicine
    Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
  • 2020
TLDR
A Caucasian 73 year old woman who, after an episode of gross hematuria, underwent an ultrasound of the urinary system, a cystoscopy and a total body computed tomography which confirmed the presence of a bladder neoformation, is presented.
T1 bladder cancer: current considerations for diagnosis and management
TLDR
It is hypothesized that the variability in the outcomes of patients with T1 bladder cancer is a result of both tumour heterogeneity and pathological staging, as well as inconsistencies in risk stratification, endoscopic resection and schedules of delivery of BCG.
Clinical Characteristics and Prognosis of Rare Histological Variants of Bladder Cancer: A Single-Center Retrospective Study from China
TLDR
Considering a high recurrence following transurethral resection of bladder tumor and IVT, early radical cystectomy (RC) might be performed for patients with RHV-BC.
Accuracy and prognostic value of radiological lymph node features in variant histologies of bladder cancer
TLDR
An accuracy of UV and NUV comparable to UC with low specificity for all variant histologies is revealed and CT scan prior RC should be interpreted in regard to histological subtypes.
Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy
TLDR
The aim of this review was to summarize the main morphologic features of UTUC as well as the current status and future role of its molecular characterization in diagnosis, prognosis, and therapy.
...
...

References

SHOWING 1-10 OF 155 REFERENCES
Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications
  • M. Amin
  • Medicine
    Modern Pathology
  • 2009
TLDR
This review discusses the variants of urothelial carcinoma, outlining for each the diagnostic features, differential diagnostic considerations and the clinical significance.
Should histologic variants alter definitive treatment of bladder cancer?
TLDR
This review outlines the current evidence and determines whether histologic variants should indeed alter definitive treatment, and if variant architecture truly identifies high-risk patients, or those with a differential response to therapy, than treatment algorithms should be altered.
Impact of histological variants on the outcomes of nonmuscle invasive bladder cancer after transurethral resection
TLDR
The existence of histological variants after TURB appears to massively impact NMIBC outcomes, with the presence of these variants often indicates poor prognosis with increased risk for recurrence and progression.
Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder
TLDR
In samples of limited volume, nested variant of urothelial bladder carcinoma is typically associated with advanced stage and may be misdiagnosed as proliferation of von Brunn nests or other nested-like bladder lesions, delaying definitive therapy.
Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
TLDR
Patients suffering from PUC have the worst clinical outcome regarding overall survival compared to conventional UC and MPC of the bladder that in turn seem have to best clinical outcome.
...
...